Episode 31: The GLP-1 Crackdown, Microdosing, and the Future of Metabolic Health with Dr. Dean Jones

February 13
32 mins

Episode Description

Welcome back to Peptides for Women podcast! 

In this episode, I’m joined by Dr. Dean Jones, and we’re diving into what’s really happening in the peptide and GLP-1 space right now. This is an important, timely conversation about regulation, safety, dosing, and why so much of the current GLP-1 messaging online is missing the bigger picture, especially for midlife women.

We talk about the growing scrutiny around research peptides, why GLP-1s are under the microscope, and how fear-based headlines are creating confusion for patients. Dr. Jones explains the difference between aggressive weight-loss dosing and more conservative, long-term metabolic dosing, why microdosing is gaining traction, and how GLP-1s actually work in the brain and body beyond appetite suppression. If you’re trying to understand GLP-1s without hype (or panic), this episode brings clarity.

In this episode, we cover:

  • Why GLP-1s are facing increased regulatory scrutiny
  • The difference between research peptides and prescription use
  • How misinformation is shaping public fear around GLP-1s
  • Why high dosing often backfires long-term
  • What microdosing GLP-1s is, and who it’s for
  • Appetite regulation vs true metabolic support
  • Food noise, weight regain, and brain signaling
  • Muscle loss concerns and how dosing impacts outcomes
  • Why lowest effective dose matters for sustainability
  • What the future of GLP-1 therapy may look like

Connect with Dr. Jones, DC!

Links & Resources:

‼️Disclaimer‼️

This podcast is for informational purposes only and does not provide medical advice. Always speak with your licensed healthcare provider before starting or changing any medication or treatment plan.

See all episodes